Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
226.5 USD | -2.60% | -1.94% | -4.56% |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.56% | 11.98B | |
+31.56% | 49.46B | |
+2.08% | 42.58B | |
+49.11% | 42.49B | |
-5.26% | 29.09B | |
+12.70% | 26.61B | |
-23.53% | 18.64B | |
+8.13% | 13.16B | |
+31.32% | 12.55B | |
+24.08% | 12.1B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Transcript : Charles River Laboratories International, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 10